Table of Contents

1 Study Coverage

• 1.1 Medical Hemostatic Agents Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Medical Hemostatic Agents Market Size Growth Rate by Product
  • 1.4.2 Gelation Sponge
  • 1.4.3 Oxidized Regenerated Cellulose Based Hemostats
  • 1.4.4 Others
• 1.5 Market by End User
  • 1.5.1 Global Medical Hemostatic Agents Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Surgical Centers
  • 1.5.4 Clnics
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Medical Hemostatic Agents Market Size
  • 2.1.1 Global Medical Hemostatic Agents Revenue 2014-2025
  • 2.1.2 Global Medical Hemostatic Agents Sales 2014-2025
• 2.2 Medical Hemostatic Agents Growth Rate by Regions
  • 2.2.1 Global Medical Hemostatic Agents Sales by Regions
  • 2.2.2 Global Medical Hemostatic Agents Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Medical Hemostatic Agents Sales by Manufacturers
  • 3.1.1 Medical Hemostatic Agents Sales by Manufacturers
  • 3.1.2 Medical Hemostatic Agents Sales Market Share by Manufacturers
  • 3.1.3 Global Medical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
• 3.2 Medical Hemostatic Agents Revenue by Manufacturers
  • 3.2.1 Medical Hemostatic Agents Revenue by Manufacturers (2014-2019)
  • 3.2.2 Medical Hemostatic Agents Revenue Share by Manufacturers (2014-2019)
• 3.3 Medical Hemostatic Agents Price by Manufacturers
• 3.4 Medical Hemostatic Agents Manufacturing Base Distribution, Product Types
  • 3.4.1 Medical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Medical Hemostatic Agents Product Type
  • 3.4.3 Date of International Manufacturers Enter into Medical Hemostatic Agents Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Medical Hemostatic Agents Sales by Product
• 4.2 Global Medical Hemostatic Agents Revenue by Product
• 4.3 Medical Hemostatic Agents Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Medical Hemostatic Agents Breakdown Data by End User

6 North America

• 6.1 North America Medical Hemostatic Agents by Countries
  • 6.1.1 North America Medical Hemostatic Agents Sales by Countries
  • 6.1.2 North America Medical Hemostatic Agents Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Medical Hemostatic Agents by Product
• 6.3 North America Medical Hemostatic Agents by End User

7 Europe

• 7.1 Europe Medical Hemostatic Agents by Countries
  • 7.1.1 Europe Medical Hemostatic Agents Sales by Countries
  • 7.1.2 Europe Medical Hemostatic Agents Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Medical Hemostatic Agents by Product
• 7.3 Europe Medical Hemostatic Agents by End User

8 Asia Pacific

• 8.1 Asia Pacific Medical Hemostatic Agents by Countries
  • 8.1.1 Asia Pacific Medical Hemostatic Agents Sales by Countries
  • 8.1.2 Asia Pacific Medical Hemostatic Agents Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Medical Hemostatic Agents by Product
• 8.3 Asia Pacific Medical Hemostatic Agents by End User

9 Central & South America

• 9.1 Central & South America Medical Hemostatic Agents by Countries
  • 9.1.1 Central & South America Medical Hemostatic Agents Sales by Countries
  • 9.1.2 Central & South America Medical Hemostatic Agents Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Medical Hemostatic Agents by Product
• 9.3 Central & South America Medical Hemostatic Agents by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Medical Hemostatic Agents by Countries
  • 10.1.1 Middle East and Africa Medical Hemostatic Agents Sales by Countries
  • 10.1.2 Middle East and Africa Medical Hemostatic Agents Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Medical Hemostatic Agents by Product
• 10.3 Middle East and Africa Medical Hemostatic Agents by End User

11 Company Profiles

• 11.1 Ethicon
  • 11.1.1 Ethicon Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Ethicon Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Ethicon Medical Hemostatic Agents Products Offered
  • 11.1.5 Ethicon Recent Development
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pfizer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pfizer Medical Hemostatic Agents Products Offered
  • 11.2.5 Pfizer Recent Development
• 11.3 Baxter International
  • 11.3.1 Baxter International Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Baxter International Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Baxter International Medical Hemostatic Agents Products Offered
  • 11.3.5 Baxter International Recent Development
• 11.4 C. R. Bard
  • 11.4.1 C. R. Bard Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 C. R. Bard Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 C. R. Bard Medical Hemostatic Agents Products Offered
  • 11.4.5 C. R. Bard Recent Development
• 11.5 The Medicines Company
  • 11.5.1 The Medicines Company Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 The Medicines Company Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 The Medicines Company Medical Hemostatic Agents Products Offered
  • 11.5.5 The Medicines Company Recent Development
• 11.6 Anika Therapeutics
  • 11.6.1 Anika Therapeutics Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Anika Therapeutics Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Anika Therapeutics Medical Hemostatic Agents Products Offered
  • 11.6.5 Anika Therapeutics Recent Development
• 11.7 Advanced Medical Solutions
  • 11.7.1 Advanced Medical Solutions Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Advanced Medical Solutions Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Advanced Medical Solutions Medical Hemostatic Agents Products Offered
  • 11.7.5 Advanced Medical Solutions Recent Development
• 11.8 Integra LifeSciences
  • 11.8.1 Integra LifeSciences Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Integra LifeSciences Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Integra LifeSciences Medical Hemostatic Agents Products Offered
  • 11.8.5 Integra LifeSciences Recent Development
• 11.9 B Braun Melsungen
  • 11.9.1 B Braun Melsungen Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 B Braun Melsungen Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 B Braun Melsungen Medical Hemostatic Agents Products Offered
  • 11.9.5 B Braun Melsungen Recent Development
• 11.10 Gelita Medical
  • 11.10.1 Gelita Medical Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Gelita Medical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Gelita Medical Medical Hemostatic Agents Products Offered
  • 11.10.5 Gelita Medical Recent Development
• 11.11 Equimedical
• 11.12 Vascular Solutions
• 11.13 Marine Polymer Technologies
• 11.14 Z-Medica
• 11.15 CryoLife
• 11.16 BioCer Entwicklungs
• 11.17 Biom’Up SAS

12 Future Forecast

• 12.1 Medical Hemostatic Agents Market Forecast by Regions
  • 12.1.1 Global Medical Hemostatic Agents Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Medical Hemostatic Agents Revenue Forecast by Regions 2019-2025
• 12.2 Medical Hemostatic Agents Market Forecast by Product
  • 12.2.1 Global Medical Hemostatic Agents Sales Forecast by Product 2019-2025
  • 12.2.2 Global Medical Hemostatic Agents Revenue Forecast by Product 2019-2025
• 12.3 Medical Hemostatic Agents Market Forecast by End User
• 12.4 North America Medical Hemostatic Agents Forecast
• 12.5 Europe Medical Hemostatic Agents Forecast
• 12.6 Asia Pacific Medical Hemostatic Agents Forecast
• 12.7 Central & South America Medical Hemostatic Agents Forecast
• 12.8 Middle East and Africa Medical Hemostatic Agents Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Medical Hemostatic Agents Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Medical Hemostatic Agents market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Medical Hemostatic Agents market based on company, product type, end user and key regions.

This report studies the global market size of Medical Hemostatic Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Medical Hemostatic Agents in these regions.
This research report categorizes the global Medical Hemostatic Agents market by top players/brands, region, type and end user. This report also studies the global Medical Hemostatic Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS

Market size by Product
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Market size by End User
Hospitals
Surgical Centers
Clnics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Medical Hemostatic Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Medical Hemostatic Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Medical Hemostatic Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Medical Hemostatic Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Medical Hemostatic Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Medical Hemostatic Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.